Veer Bhavnagri, General Counsel at Allogene Therapeutics, Inc. (ALLO), sold 3,000 shares at $7.04 ($21K) on 2023-01-17, disclosed to the SEC on 2023-01-18.
Scheduled sale ($21k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALLO | SELL | 2022-03-17 | $136K | — | Filing → |
| ALLO | SELL | 2021-09-17 | $124K | — | Filing → |
| ALLO | SELL | 2021-08-17 | $105K | — | Filing → |